Study gut and skin germs in vitiligo progression
Part of Skin clinical trials.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 89 years old
- You can understand and sign consent to join the study
- You have vitiligo, or you do not have vitiligo (controls)
- If you have vitiligo: you may or may not have had new spreading in the last year
- If you are a control: you do not have a vitiligo diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study uses a simple blood test to measure immune system signals (cytokines) that may indicate whether vitiligo is active or stable. The goal is to create a model that helps predict how the disease may progress.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
This study is creating a registry (a secure database) to track the health and treatment of children and adults with vitiligo in the UK. Joining helps researchers learn more about vitiligo and improve future care.
This study uses dermoscopy (a special magnifying tool) to look at nails in people with vitiligo. It helps check if nail changes can give doctors more information about the condition.
This study looks at whether commonly used topical (skin) medications change your skin and gut microbial “ecosystem.” It’s an early (Phase 1) pilot study, mainly to see how these treatments affect samples over time.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.